Westley Nolin

Westley (Wes) Nolin is a member of the life sciences team at Morningside Venture Investments where he has for the last ten years performed scientific diligence and assessment for venture capital investments. Wes currently sits on the Board of Directors of several Morningside portfolio companies. Dr. Nolin received a B.S. from St. Lawrence University and a Ph.D. from Stony Brook University where he completed his doctoral training in the field of Molecular and Cellular Biology with a specialization in immunology. Prior to graduate school he worked at the Center for Blood Research/Harvard Medical School, studying the molecular role of surfactants in inflammatory lung disease.